[儿科质瘤的临床病理和分子特征:111例病例的分析]
1Department of Pathology, Guangzhou Medical University Affiliated Women and Children's Medical Center, Guangzhou 510623, China.
Zhonghua bing li xue za zhi = Chinese journal of pathology
|September 4, 2024
概括
儿科质瘤,包括儿科扩散低度质瘤 (pDLGG),局限性星细胞质瘤 (CAG) 和儿科扩散高度质瘤 (pDHGG),表现出明显的临床,病理和分子差异. 结合组织学和分子特征的综合诊断对于准确的儿科质瘤分类和治疗至关重要.
科学领域:
- 神经瘤学神经瘤学
- 儿科病理学 儿科病理学
- 分子诊断学 分子诊断
背景情况:
- 儿科质瘤是各种各样的中枢神经系统瘤,具有不同的临床行为.
- 准确的分类对于有效的治疗策略至关重要.
研究的目的:
- 总结和比较不同小儿质瘤亚型的临床,病理和分子特征.
- 探索综合性遗传病理学和分子分析的诊断意义.
主要方法:
- 根据世卫组织第5版中枢神经系统瘤分类,对111种儿科质瘤的分类.
- 分析临床数据,成像发现,组织病理学和分子变化 (免疫组织化学和遗传检测).
- 用于比较分析的文献综述.
主要成果:
- 在儿科扩散性低度质瘤 (pDLGG),局限性星细胞质瘤 (CAG) 和儿科扩散性高度质瘤 (pDHGG) 之间观察到年龄,临床表现,瘤位置和成像发现的显著差异.
- 分子分析显示了不同的基因变异:pDLGG/CAG中的KIAA1549-BRAF融合和BRAF V600E突变,与pDHGG中的HIST1H3B,H3F3A突变,1q放大和TP53突变相对应.
- 综合诊断在35.3%的病例中改进了病理分类,这些病例以前仅通过组织学无法分类.
结论:
- 儿科质瘤亚型 (pDLGG,CAG,pDHGG) 在临床,病理和分子形状上表现出显著的差异,影响预后.
- 结合组织学和分子数据对于准确的诊断和指导儿科质瘤治疗决策至关重要.
更多相关视频
06:32Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
7.8K
07:39Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
Published on: November 17, 2021
3.5K
相关概念视频
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...